ReviewSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2026
[Nanomaterial-driven Lateral Flow Immunoassay: Technological Development and Application].
Review in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In clinical testing, traditional research has focused on developing large analytical instruments capable of processing high sample volumes with fully automated and highly sensitive measurements. In recent years, however, there has been increasing demand for analytical reagents for point-of-care testing (POCT), which do not require a specific location or professional operators. This trend is exemplified by the lateral flow immunoassay (LIFA), favored for its simple operation, rapid results, and user-friendly design. The fiber membrane-based structure of LIFA provides both cost-effectiveness and ease of disposal, addressing key concerns related to testing budgets and environments. Despite its compact size, LIFA incorporates multiple technological innovations, reflecting years of research and development. Current studies focus on advancing LIFA technology, paving the way for next-generation diagnostic devices. These advancements aim to redefine testing convenience and enhance the capacity to respond effectively to urgent public health challenges. The future of LIFA is gradually unfolding, with deeper integration into daily health management and emergency response systems. In this review, we present the historical development of LIFA and several cutting-edge LIFA technologies, including gold nanoparticle-based, magnetic, photothermal, fluorescent, and surface-enhanced Raman scattering approaches, aiming to inspire future LIFA research and development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.